Login / Signup

[Severe gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants (based on REGistry of long-term AnTithrombotic TherApy - REGATTA)].

E S KropachevaM B KhakimovaE N KrivosheevaO A ZemlyanskayaE P Panchenko
Published in: Terapevticheskii arkhiv (2021)
Searching for clinical predictors of gastrointestinal bleeding can identify patients receiving oral anticoagulants who is need of intensive monitoring risk factors to prevent the development of life-threatening bleeding and to provide with adequate anticoagulant therapy.
Keyphrases
  • atrial fibrillation
  • oral anticoagulants
  • risk factors
  • stem cells